Anti-inflammatory role in septic shock of pituitary adenylate cyclase-activating polypeptide receptor.
about
The neuropeptide vasoactive intestinal peptide: direct effects on immune cells and involvement in inflammatory and autoimmune diseasesAltered anti-inflammatory response of mononuclear cells to neuropeptide PACAP is associated with deregulation of NF-{kappa}B in chronic pancreatitis.Vasoactive intestinal peptide increases hepatic transduction and reduces innate immune response following administration of helper-dependent Ad.VIP enhances phagocytosis of fibrillar beta-amyloid by microglia and attenuates amyloid deposition in the brain of APP/PS1 miceVasoactive intestinal peptide: a neuropeptide with pleiotropic immune functions.Pituitary adenylate cyclase activating polypeptide: an important vascular regulator in human skin in vivo.Therapeutic potential of vasoactive intestinal peptide and its receptors in neurological disorders.Endogenous PACAP acts as a stress response peptide to protect cerebellar neurons from ethanol or oxidative insultMonitoring immune dysfunctions in the septic patient: a new skin for the old ceremony.Pituitary adenylate cyclase-activating polypeptide (PACAP) decreases ischemic neuronal cell death in association with IL-6.VIP and PACAP: recent insights into their functions/roles in physiology and disease from molecular and genetic studies.Targeting VIP and PACAP receptor signalling: new therapeutic strategies in multiple sclerosis.Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1.Tuning inflammation with anti-inflammatory neuropeptides.Tuning immune tolerance with vasoactive intestinal peptide: a new therapeutic approach for immune disordersVIP and PACAP: neuropeptide modulators of CNS inflammation, injury, and repairPituitary adenylate cyclase-activating peptide receptor 1 mediates anti-inflammatory effects in allergic airway inflammation in mice.Emerging roles of vasoactive intestinal peptide: a new approach for autoimmune therapy.Endogenous anti-inflammatory neuropeptides and pro-resolving lipid mediators: a new therapeutic approach for immune disorders.Neuropeptide receptors as potential drug targets in the treatment of inflammatory conditionsNeuropeptides as pleiotropic modulators of the immune response.Parasympathetic innervation of vertebrobasilar arteries: is this a potential clinical target?Nociceptor Sensory Neuron-Immune Interactions in Pain and Inflammation.PACAP protects against inflammatory-mediated toxicity in dopaminergic SH-SY5Y cells: implication for Parkinson's disease.A new recombinant pituitary adenylate cyclase-activating peptide-derived peptide efficiently promotes glucose uptake and glucose-dependent insulin secretion.Neural pathways in allergic inflammation.Neuropeptides rescue mice from lethal sepsis by down-regulating secretion of the late-acting inflammatory mediator high mobility group box 1.PACAP38 suppresses cortical damage in mice with traumatic brain injury by enhancing antioxidant activity.The effects of Fructus Aurantii extract on the 5-hydroxytryptamine and vasoactive intestinal peptide contents of the rat gastrointestinal tract.VIP modulates IL-22R1 expression and prevents the contribution of rheumatoid synovial fibroblasts to IL-22-mediated joint destruction.
P2860
Q26851670-50A0A799-F42E-4E1F-B06E-CBE10B23CC4FQ33303975-7CCB8379-08D4-4072-ACEB-6C620D3EA92CQ34025143-F1F74A0C-4D5F-4C1C-9FF2-3218DD6CB632Q34157261-60D1391A-E87B-4705-87F1-26F6E3C31414Q34238010-B9339CC9-8FD9-4EE7-9C33-094B556BE993Q34254582-DD7B1CEF-615A-4DFA-B903-0FD554842C3CQ34259060-5C6DC853-81F8-492D-9530-81E3494862D2Q34280402-4696AAC2-1E75-49E2-8432-ECA0B07B9DC0Q34585151-8A492A9C-0430-45FF-8A6C-894E515CD201Q34624638-ACC12FA4-F6B6-4D8D-920B-FC28BF9EA681Q34788079-EA9E4618-BDCC-4FE4-B5CD-CB754CB564DFQ35295564-554854AD-78A6-43D3-ABB3-2AB312FF093EQ36153216-E3536220-30AB-4DAC-BC1B-2C6CB1681EA0Q36764912-11F95DDF-DAA1-4441-9497-ACB79B8833EEQ36830470-3F155C41-41DE-4D55-90C8-10790D1A98AEQ36929423-A996F027-09A5-419D-B722-FECD770EA3A9Q36959866-0A1A5CF4-A4DC-42CB-BBB1-DBA379293BD2Q36969911-11986F3B-56F6-4488-B9FD-5CA8F72C5ACAQ37191369-926D4BE7-E711-46B3-8EF5-71C0A89D726FQ37492012-521652F1-7625-4137-8598-9B7A5D5D8067Q37898396-9686C5F2-F762-47A1-B639-790069A5852CQ38880941-10909162-5C80-4BF6-8498-37C89F575938Q38994025-CC43DFC0-D8D3-4A33-A92A-ABD501621DB7Q39003365-FC75EEC4-86FE-4818-828D-8A36DBE35779Q39262582-56493D31-19CE-4DFE-B62A-8E02F9166078Q42599914-83A4D43C-460C-46CF-841F-5E879A17A598Q43160552-332B47EA-2A48-495C-ACC7-4F2E158FA9D3Q46882701-DD1BCBC2-D3FC-4687-94EF-CB7A7B5E9585Q53580701-BD264CF4-9F51-4218-B596-46FF3A1B0879Q54569255-51404F74-93FC-45D7-8E2C-9F19306BF497
P2860
Anti-inflammatory role in septic shock of pituitary adenylate cyclase-activating polypeptide receptor.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Anti-inflammatory role in sept ...... tivating polypeptide receptor.
@ast
Anti-inflammatory role in sept ...... tivating polypeptide receptor.
@en
type
label
Anti-inflammatory role in sept ...... tivating polypeptide receptor.
@ast
Anti-inflammatory role in sept ...... tivating polypeptide receptor.
@en
prefLabel
Anti-inflammatory role in sept ...... tivating polypeptide receptor.
@ast
Anti-inflammatory role in sept ...... tivating polypeptide receptor.
@en
P2093
P2860
P50
P356
P1476
Anti-inflammatory role in sept ...... ctivating polypeptide receptor
@en
P2093
Alicia Arranz
Carmen Martinez
Javier Leceta
Maria G Juarranz
Nieves Rodriguez-Henche
Rosa P Gomariz
P2860
P304
P356
10.1073/PNAS.012367999
P407
P577
2002-01-15T00:00:00Z